Market Overview:
The global edible vaccine market is expected to grow at a CAGR of over 9% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidences of foodborne diseases, increasing demand for livestock vaccines, and growing awareness about edible vaccines. In terms of type, the inactivated vaccine segment is expected to lead the global edible vaccine market during the forecast period. This can be attributed to factors such as increasing demand for safe and efficacious vaccines and rising incidence of foodborne diseases. By application, medical care is expected to account for a major share of the global edible vaccine market during the forecast period.
Product Definition:
An edible vaccine is a vaccine that is made from food ingredients. Edible vaccines are important because they can help to prevent disease by providing immunity against diseases.
Inactivated Vaccines:
Inactivated vaccines are made by heating the virus to a temperature high enough to inactivate it. The vaccine is then ready for use, and can be administered to an individual without causing them harm. In most cases, these vaccines are given to people suffering from weakened immune systems such as patients with AIDS or cancer.
The global increase in infectious diseases such as chickenpox, measles, mumps, rubella.
Others:
Others are the ingredients that are not part of the vaccine itself but help in its production. Others include adjuvants, carriers, diluents and excipients. The function of others is to increase the efficacy of a vaccine by increasing its ability to stimulate an immune response or by improving its immunogenicity.
Application Insights:
The medical care application segment accounted for the largest revenue share in 2017 and is anticipated to maintain its dominance over the forecast period. This can be attributed to growing global awareness about access to quality healthcare facilities along with increasing incidences of infectious diseases, especially among children. The livestock application segment is expected to register a significant CAGR during the forecast period owing to rising concerns regarding animal health and safety coupled with advancements in technology that have made it easier for farmers and veterinarians worldwide.
The others segment includes applications such as agriculture & farming, pet care, human nutrition supplements among others. These applications are projected witness growth opportunities due majorly on account of increased consumer awareness regarding proper food consumption habits along with rising demand for organic products across various regions including North America and Europe.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high investment by governments for development of new vaccines and growing acceptance of edible vaccines. Asia Pacific is estimated to be fastest-growing regional market over the forecast period due to increasing focus on immunization, rising awareness about vaccine benefits, improving healthcare infrastructure and economic development in emerging countries such as China and India. Moreover, increasing number of clinical trials for edible vaccines will drive demand further. For instance, a phase I/IIa clinical trial was conducted with an aim toward evaluation of safety and immunogenicity of two different formulations (powdered or liquid) of MVA against yellow fever virus infection in healthy adults from India (Ref).
Growth Factors:
- Increasing awareness about the benefits of edible vaccines over traditional vaccines.
- Rising demand for novel vaccine delivery platforms such as edible vaccines.
- Growing number of public-private partnerships to develop and commercialize edible vaccines.
- increasing prevalence of infectious diseases that can be prevented through vaccination
Scope Of The Report
Report Attributes
Report Details
Report Title
Edible Vaccine Market Research Report
By Type
Inactivated Vaccines, Others
By Application
Medical Care, Livestock, Others
By Companies
GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health, Ceva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Edible Vaccine Market Report Segments:
The global Edible Vaccine market is segmented on the basis of:
Types
Inactivated Vaccines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Care, Livestock, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Sanofi
- Merck
- Merial
- Santa Cruz Animal Health
- Ceva
Highlights of The Edible Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inactivated Vaccines
- Others
- By Application:
- Medical Care
- Livestock
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Edible Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Edible vaccines are vaccines that are made from food products. They can be eaten as snacks or incorporated into other foods.
Some of the major players in the edible vaccine market are GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health, Ceva.
The edible vaccine market is expected to register a CAGR of 9%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Edible Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Edible Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Edible Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Edible Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Edible Vaccine Market Size & Forecast, 2018-2028
4.5.1 Edible Vaccine Market Size and Y-o-Y Growth
4.5.2 Edible Vaccine Market Absolute $ Opportunity
Chapter 5 Global Edible Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Edible Vaccine Market Size Forecast by Type
5.2.1 Inactivated Vaccines
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Edible Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Edible Vaccine Market Size Forecast by Applications
6.2.1 Medical Care
6.2.2 Livestock
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Edible Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Edible Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Edible Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Edible Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Edible Vaccine Market Size Forecast by Type
9.6.1 Inactivated Vaccines
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Edible Vaccine Market Size Forecast by Applications
9.10.1 Medical Care
9.10.2 Livestock
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Edible Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Edible Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Edible Vaccine Market Size Forecast by Type
10.6.1 Inactivated Vaccines
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Edible Vaccine Market Size Forecast by Applications
10.10.1 Medical Care
10.10.2 Livestock
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Edible Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Edible Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Edible Vaccine Market Size Forecast by Type
11.6.1 Inactivated Vaccines
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Edible Vaccine Market Size Forecast by Applications
11.10.1 Medical Care
11.10.2 Livestock
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Edible Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Edible Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Edible Vaccine Market Size Forecast by Type
12.6.1 Inactivated Vaccines
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Edible Vaccine Market Size Forecast by Applications
12.10.1 Medical Care
12.10.2 Livestock
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Edible Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Edible Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Edible Vaccine Market Size Forecast by Type
13.6.1 Inactivated Vaccines
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Edible Vaccine Market Size Forecast by Applications
13.10.1 Medical Care
13.10.2 Livestock
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Edible Vaccine Market: Competitive Dashboard
14.2 Global Edible Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Sanofi
14.3.3 Merck
14.3.4 Merial
14.3.5 Santa Cruz Animal Health
14.3.6 Ceva
